NCT00157482View on ClinicalTrials.gov

Ezetimibe and Simvastatin in Dyslipidemia of Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

December 31, 2006

Conditions
Type 2 Diabetes
Interventions
DRUG

Ezetimibe

DRUG

Simvastatin

Trial Locations (4)

24020

Clinical Research Center for Rare Diseases, Ranica

24036

ASl of Ponte San Pietro - Diabetologic Unit, Ponte San Pietro

24047

"Hospital Treviglio Caravaggio - Diabetologic Unit", Treviglio

24128

"Hospital Ospedali Riuniti di Bergamo - Diabetologic Unit", Bergamo

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00157482 - Ezetimibe and Simvastatin in Dyslipidemia of Diabetes | Biotech Hunter | Biotech Hunter